For research use only. Not for therapeutic Use.
Latanoprost-d4 is a deuterated form of latanoprost, a prostaglandin F2α analog used primarily in the treatment of glaucoma and ocular hypertension. The four deuterium atoms in latanoprost-d4 replace hydrogen atoms, providing a stable isotopic label for use in pharmacokinetic and metabolic studies. This compound allows researchers to accurately track the absorption, distribution, metabolism, and excretion of latanoprost in biological systems. Latanoprost-d4 is particularly valuable in pharmaceutical research for improving drug formulations and understanding the metabolic pathways of prostaglandin analogs. Its applications extend to medicinal chemistry and drug development for eye-related disorders.
Catalog Number | R023715 |
CAS Number | NA |
Synonyms | (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid-d4 1-Methylethyl Ester; Isopropyl-(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate-d4; PhXA-41-d4; GAAP Of |
Molecular Formula | C26H36D4O5 |
Purity | ≥95% |
Target | Prostaglandin Receptor |
Storage | -20°C |
IUPAC Name | propan-2-yl (Z)-3,3,4,4-tetradeuterio-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate |
InChI | InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1/i4D2,9D2 |
InChIKey | GGXICVAJURFBLW-XUVAVRMSSA-N |
SMILES | [2H]C([2H])(CC(=O)OC(C)C)C([2H])([2H])/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O |